Sionna Therapeutics (NASDAQ:SION) Earns Buy Rating from Analysts at Guggenheim
Guggenheim initiated coverage on shares of Sionna Therapeutics (NASDAQ:SION – Free Report) in a research report released on Tuesday morning, Marketbeat.com reports. The firm issued a buy rating and a $45.00 price objective on the stock. Sionna Therapeutics Stock Down 5.0 % Shares of SION opened at $15.65 on Tuesday. Sionna Therapeutics has a fifty-two […]
Guggenheim initiated coverage on shares of Sionna Therapeutics (NASDAQ:SION – Free Report) in a research report released on Tuesday morning, Marketbeat.com reports. The firm issued a buy rating and a $45.00 price objective on the stock. Sionna Therapeutics Stock Down 5.0 % Shares of SION opened at $15.65 on Tuesday. Sionna Therapeutics has a fifty-two […]
